Skip to content

ABVX - Abivax S.A. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchA

Abivax SA American Depositary Shares

ABVX · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

A

ABVXAbivax SA American Depositary Shares

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $148.83
52-wk low: $69.81
Prev close: $104.18
Mkt cap: $10.31B
Beta: -0.23
P/S: 2096.1x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$565.1M

CI
Citadel
Ken Griffin · Q2 2026 13F
$191.7M
position
BA
Balyasny
Dmitry Balyasny · Q2 2026 13F

Earnings

Reported May 22, 2026

Earnings came in 12.8% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $10.3B

Valuation

P/S2096.13
P/B21.14

Quality

Operating margin-4184.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: ABVX
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $10.31B
Beta: -0.23

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

21.1x

Profit margin

+0.0%

Op margin

-4184.0%

ROE

-157.1%

$80.5M

position

MI

Millennium

Israel Englander · Q2 2026 13F

$31.1M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for ABVX

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.71+12.8%

-$0.81 expected

Next report

Reports Sep 14, 2026, in 24 days

EPS expected

-$0.67

-$0.88 to -$0.48

Revenue expected

$817.3K

5 analysts

Last 30 days

2up0down

Analysts raising estimates

Estimate drift

0.07

Change in 30 days

-157.1%

ROA-44.7%

Growth

Beta-0.23